Navigation Links
Tailoring Breast Cancer Treatment, from Harvard Women's Health Watch
Date:10/6/2009

Breast cancer, once thought to be a single disease, is turning out to be a collection of somewhat different disorders.

Boston, MA (Vocus) October 6, 2009 -- Breast cancer, once thought to be a single disease, is turning out to be a collection of somewhat different disorders. That knowledge is tempering the approach to treatment as experts begin using gene-based information to individualize therapies, reports the October 2009 issue of Harvard Women's Health Watch.

A key focus of breast cancer research today is identifying specific genes and protein receptors that can distinguish resistant forms of cancer from those that are easier to eradicate. In the process, it has become clear that breast cancer comes in different forms that respond to varying treatments.

The discovery of the BRCA genes in 1994 transformed approaches to prevention in women who are at high risk for breast cancer. Women carrying one of these harmful genes have options: screening via frequent mammograms and breast MRI scans, taking the drug tamoxifen to reduce the risk, or undergoing double mastectomy. Most breast cancer, though, isn't hereditary. Gene mutations are involved, but rather than being passed down from generation to generation, they crop up when errors occur in the DNA duplication process during cell division.

Advances in understanding the molecular basis of cancer have led to greater precision in identifying which tumors are more likely to recur and in targeting treatment. Harvard Women's Health Watch notes that cancer specialists are using gene-based diagnostic tests in various ways to plan more effective treatments: to determine which women are at high risk of recurrence and could benefit from chemotherapy in addition to tamoxifen; to identify women who might benefit from chemotherapy along with the drug Herceptin before surgery; and to identify women who carry certain forms of genes that help metabolize specific drugs.

Read the full-length article: "Molecular advances in early breast cancer"
Also in this issue:

 
  • Going vegetarian
  • New osteoporosis drug
  • Psychodynamic therapy for anxiety
  • Renessa for urinary incontinence
  • Knee replacement

Harvard Women's Health Watch is available from Harvard Health Publications (www.health.harvard.edu), the publishing division of Harvard Medical School, for $28 per year. Subscribe at www.health.harvard.edu/womens or by calling 877-649-9457 (toll-free).

Media: Contact Raquel Schott at Raquel_Schott@hms.harvard.edu for a complimentary copy of the newsletter, or to receive our press releases directly.

Contact:
Raquel Schott
Harvard Health Publications
617-432-5781

# # #

Read the full story at http://www.prweb.com/releases/breast_cancer/treatment/prweb3002894.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Tailoring glioblastoma therapies: 1 size does not fit all
2. The Childrens Hospital of Philadelphia Receives Grant to Study Tailoring Pediatric Preventive Care to Individual Needs
3. An Aid to Tailoring Prostate Cancer Treatment
4. Japanese Fine Tailoring Revolutionizes Traditional Doctor Coats
5. Survival differences by race most apparent in advanced stages of breast cancer
6. MRI finds breast cancer before it becomes dangerous
7. Pathway links inflammation, angiogenesis and breast cancer
8. Drop in breast cancer incidence linked to hormone use, not mammograms
9. Breast cancer prevention practices vary across Canada
10. Eating junk food whilst pregnant and breastfeeding may lead to obese offspring
11. Acrylamide Wont Raise Breast Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Frederick area economy by obtaining investment capital for emerging technology companies. ... years that have already resulted in more than a million dollars of capital ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals plc ... period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, ... of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ... (Eastern Daylight Time). As previously announced on ... a definitive merger agreement under which Jazz Pharmaceuticals has ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: